Serina Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Serina Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • Serina Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $6.7M, a 108% increase year-over-year.
  • Serina Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$3.89M, a 159% decline year-over-year.
  • Serina Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$4.92M, a 38.8% decline from 2022.
  • Serina Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$3.55M, a 447% decline from 2021.
  • Serina Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$649K, a 117% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4.92M -$1.38M -38.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 -$3.55M -$2.9M -447% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 -$649K -$350K -117% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$299K -$622K -193% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $323K -$3.19M -90.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $3.51M +$3.49M +13415% Jan 1, 2018 Dec 31, 2018 10-K/A 2020-03-31
2017 $26K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.